TNF and diabetes mellitus: Functional studies show that a TNF inhibitor significantly reduces expression of other cytokines, diminishes leukocyte infiltration and bone resorption in diabetic rats, indicating that cytokine dyregulation is an essential component of diabetes-enhanced periodontal bone loss in vivo (158).